Exact Mass: 317.0512
Exact Mass Matches: 317.0512
Found 43 metabolites which its exact mass value is equals to given mass value 317.0512,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanate
2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanic acid
1-{3-[(4-chlorophenyl)sulfonyl]-2-hydroxypropyl}-2-pyrrolidinone
1-{3-[(4-chlorophenyl)sulfonyl]-2-hydroxypropyl}-2-pyrrolidinone
tert-Butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate
tert-Butyl 3-(((trifluoromethyl)sulfonyl)oxy)-2,5-dihydro-1H-pyrrole-1-carboxylate
2,5-DIOXOPYRROLIDIN-1-YL 7-METHOXY-2-OXO-2H-CHROMENE-3-CARBOXYLATE
2,5-DIOXOPYRROLIDIN-1-YL 7-METHOXY-2-OXO-2H-CHROMENE-3-CARBOXYLATE
2-[(2,4-dichloropyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethyl-trimethylsilane
2-[(2,4-dichloropyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethyl-trimethylsilane
1H-Pyrrolo[2,3-b]pyridine, 1-[(4-methylphenyl)sulfonyl]-4-nitro-
1H-Pyrrolo[2,3-b]pyridine, 1-[(4-methylphenyl)sulfonyl]-4-nitro-
Dabuzalgron
Dabuzalgron
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Dabuzalgron (Ro 115-1240) is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1].
rac 6-Chloro-1,4-dihydro-4-(1-pentynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
rac 6-Chloro-1,4-dihydro-4-(1-pentynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-[(E)-2-cyclopropylvinyl]-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-[(E)-2-cyclopropylvinyl]-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
2-(4-chlorophenyl)7-methyl-5-oxo-2-phenyl-5H-imidazo1,2-aüpyrimidin-8(5H)-ylüacetic acid
2-(4-chlorophenyl)7-methyl-5-oxo-2-phenyl-5H-imidazo1,2-aüpyrimidin-8(5H)-ylüacetic acid
Ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate
Ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate
(5Z)-3-ethyl-5-[(2-methyl-2H-chromen-3-yl)methylene]-2-thioxo-thiazolidin-4-one
(5Z)-3-ethyl-5-[(2-methyl-2H-chromen-3-yl)methylene]-2-thioxo-thiazolidin-4-one
N-(1,3-benzodioxol-5-yl)-5-oxo-2,3-dihydrothiazolo[3,2-a]pyrimidine-6-carboxamide
N-(1,3-benzodioxol-5-yl)-5-oxo-2,3-dihydrothiazolo[3,2-a]pyrimidine-6-carboxamide
5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate
5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(2-nitrophenyl)sulfanyloxane-3,4,5-triol
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(2-nitrophenyl)sulfanyloxane-3,4,5-triol
5-(2-Chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-(dihydroxyamino)-1,3-dihydro-1,4-benzodiazepin-2-one
(4s,5s)-1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one
(4s,5s)-1,1-dichloro-4-ethyl-5-(4-nitrophenyl)hexan-2-one
(4r)-2-hydroxy-4-[(s)-hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one
(4r)-2-hydroxy-4-[(s)-hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one
2-hydroxy-4-[hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one
2-hydroxy-4-[hydroxy(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)methyl]-1,3,2λ⁵-dioxaphospholan-2-one
(2-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}ethyl)dimethylamine
(2-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}ethyl)dimethylamine
